| Schedule of Restricted Stock Awards |
The following table summarizes the Company's RSA activity for the nine months ended September 30, 2026 and 2025: | | | | | | | | | | | | | | | | | | | | | | | | | Nine Months Ended September 30, | | 2026 | | 2025 | | Number of Shares | | Weighted-Average Grant Date Fair Value | | Number of Shares | | Weighted-Average Grant Date Fair Value | | Outstanding at beginning of period | 67,365 | | | $ | 27.43 | | | 36,346 | | | $ | 38.11 | | | Granted | 44,219 | | | $ | 26.12 | | | 64,070 | | | $ | 27.86 | | | Forfeited | (14,358) | | | $ | 27.86 | | | — | | | $ | — | | | Vested | (49,712) | | | $ | 27.86 | | | (32,332) | | | $ | 38.20 | | | Outstanding at end of period | 47,514 | | | $ | 25.62 | | | 68,084 | | | $ | 28.42 | |
|
| Schedule of Restricted Stock Units |
The following table summarizes the Company's Time-Based RSU activity for the nine months ended September 30, 2026 and 2025: | | | | | | | | | | | | | | | | | | | | | | | | | Nine Months Ended September 30, | | 2026 | | 2025 | | Number of Shares | | Weighted-Average Grant Date Fair Value | | Number of Shares | | Weighted-Average Grant Date Fair Value | | Outstanding at beginning of period | 932,175 | | | $ | 35.95 | | | 576,652 | | | $ | 43.87 | | | Granted | 1,080,919 | | | $ | 22.53 | | | 677,853 | | | $ | 31.08 | | | Forfeited | (65,862) | | | $ | 31.01 | | | (53,320) | | | $ | 40.92 | | | Vested | (368,255) | | | $ | 35.58 | | | (242,578) | | | $ | 39.79 | | | Outstanding at end of period | 1,578,977 | | | $ | 27.06 | | | 958,607 | | | $ | 35.92 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
The following table summarizes the Company's Performance-Based RSU activity for the nine months ended September 30, 2026 and 2025: | | | | | | | | | | | | | | | | | | | | | | | | | Nine Months Ended September 30, | | 2026 | | 2025 | | Number of Shares | | Weighted-Average Grant Date Fair Value | | Number of Shares | | Weighted-Average Grant Date Fair Value | | Outstanding at beginning of period | 1,188,986 | | | $ | 52.49 | | | 1,768,460 | | | $ | 47.02 | | | Granted | 331,112 | | | $ | 26.89 | | | 406,265 | | | $ | 44.16 | | | Forfeited | (45,125) | | | $ | 47.32 | | | (46,356) | | | $ | 54.88 | | Vested(a) | (557,244) | | | $ | 51.73 | | | (620,326) | | | $ | 43.18 | | | Outstanding at end of period | 917,729 | | | $ | 43.96 | | | 1,508,043 | | | $ | 47.59 | |
(a) The Performance-Based RSUs vested at a weighted average of 42% of target, or 233,334 shares, and 78% of target, or 482,083 shares, during the nine months ended September 30, 2026 and 2025, respectively.
|
| Schedule of Stock Option Activity |
The following table summarizes the Company's stock options activity for the nine months ended September 30, 2026: | | | | | | | | | | | | | | | | | | | | | | | | | Nine Months Ended September 30, 2026 | | WillScot Options | | Weighted-Average Exercise Price per Share | | Converted Mobile Mini Options | | Weighted-Average Exercise Price per Share | | Outstanding at beginning of period | 754,188 | | | $ | 16.46 | | | 10,884 | | | $ | 13.08 | | | Granted | 100,000 | | | $ | 18.83 | | | — | | | $ | — | | | | | | | | | | | Exercised | (408,497) | | | $ | 13.60 | | | (10,884) | | | $ | 13.08 | | | Outstanding at end of period | 445,691 | | | $ | 19.61 | | | — | | | $ | — | | | | | | | | | | | Fully vested and exercisable at end of period | 219,024 | | | $ | 17.77 | | | — | | | $ | — | |
The following table summarizes the Company's stock options activity for the nine months ended September 30, 2025: | | | | | | | | | | | | | | | | | | | | | | | | | Nine Months Ended September 30, 2025 | | WillScot Options | | Weighted-Average Exercise Price per Share | | Converted Mobile Mini Options | | Weighted-Average Exercise Price per Share | | Outstanding at beginning of period | 534,188 | | | $ | 13.60 | | | 814,889 | | | $ | 12.77 | | | Granted | 220,000 | | | $ | 23.39 | | | — | | | $ | — | | | Exercised | — | | | $ | — | | | (786,204) | | | $ | 12.77 | | | Outstanding at end of period | 754,188 | | | $ | 16.46 | | | 28,685 | | | $ | 12.86 | | | | | | | | | | | Fully vested and exercisable at end of period | 534,188 | | | $ | 13.60 | | | 28,685 | | | $ | 12.86 | |
|